Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Aug 3;10:13018. doi: 10.1038/s41598-020-70138-3

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

VIP serum levels in patients with different thyroid function status. (a) Association between VIP levels and thyroid status. ELISA determinations of VIP serum levels in 78 patients with Hashimoto’s thyroiditis (HT), 144 with Graves’ disease (GD), and 49 healthy donors (HD). (b) Association between VIP serum levels and thyroid function in patients with GD. ELISA determinations of VIP concentration in serum from 73 GD patients at the initial onset of the disease, 36 euthyroid GD patients controlled with antithyroid drugs and 35 GD hypothyroid patients due to treatment iatrogenesis. (c) Association between VIP levels and treatment groups in patients with GD. ELISA determinations of VIP concentration in serum from 73 GD patients with no treatment, 36 treated with anti-thyroid drugs, 21 treated with radioiodine and 14 that underwent surgery. Data are presented as the interquartile range (p75 upper edge of the box, p25 lower edge, p50 midline), p90 (line above the box), and p10 (line below the box) of serum VIP levels. Dots represent outliers. *P < 0.05; **P < 0.01.